Revolution Medicines (RVMD) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Revolution Medicines (RVMD) over the last 5 years, with Sep 2025 value amounting to -$1.61.
- Revolution Medicines' EPS (Weighted Average and Diluted) fell 71.28% to -$1.61 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.18, marking a year-over-year decrease of 41.53%. This contributed to the annual value of -$3.58 for FY2024, which is 7.25% up from last year.
- According to the latest figures from Q3 2025, Revolution Medicines' EPS (Weighted Average and Diluted) is -$1.61, which was down 22.90% from -$1.31 recorded in Q2 2025.
- Revolution Medicines' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.53 during Q2 2021, with a 5-year trough of -$1.61 in Q3 2025.
- For the 3-year period, Revolution Medicines' EPS (Weighted Average and Diluted) averaged around -$1.04, with its median value being -$0.99 (2023).
- In the last 5 years, Revolution Medicines' EPS (Weighted Average and Diluted) increased by 15.28% in 2022 and then crashed by 98.36% in 2023.
- Revolution Medicines' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.72 in 2021, then rose by 15.28% to -$0.61 in 2022, then slumped by 98.36% to -$1.21 in 2023, then increased by 6.61% to -$1.13 in 2024, then slumped by 71.28% to -$1.61 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.61 for Q3 2025, versus -$1.31 for Q2 2025 and -$1.13 for Q1 2025.